648430-85-7

Basic information

• Product Name: Ethyl 5-benzyl-4H-1,2,4-triazole-3-carboxylate
• Synonyms: Ethyl 5-benzyl-4H-1,2,4-triazole-3-carboxylate;ETHYL 5-BENZYL-1H-1,2,4-TRIAZOLE-3-CARBOXYLATE;1H-1,2,4-Triazole-5-carboxylic acid, 3-(phenylmethyl)-, ethyl ester
• CAS NO: 648430-85-7
• Molecular Formula: C₁₂H₁₃N₃O₂
• Molecular Weight: 231.25052
• Mol File: 648430-85-7.mol

Chemical Properties

• Boiling Point: 429.1±38.0 °C(Predicted)
• Appearance: /
• Density: 1.230±0.06 g/cm3(Predicted)
• PKA: 8.44±0.40(Predicted)
• CAS DataBase Reference: Ethyl 5-benzyl-4H-1,2,4-triazole-3-carboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: Ethyl 5-benzyl-4H-1,2,4-triazole-3-carboxylate(648430-85-7)
• EPA Substance Registry System: Ethyl 5-benzyl-4H-1,2,4-triazole-3-carboxylate(648430-85-7)

Safety Data

• Hazardous Substances Data: 648430-85-7(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
Ethyl 5-benzyl-4H-1,2,4-triazole-3-carboxylate is used as a building block for the synthesis of various pharmaceuticals due to its unique structure and reactivity, which allows for the creation of new compounds with potential therapeutic applications.
Used in Agrochemical Industry:
In the agrochemical industry, Ethyl 5-benzyl-4H-1,2,4-triazole-3-carboxylate is used as a precursor in the development of new agrochemicals, leveraging its antifungal and antibacterial properties to enhance crop protection and yield.
Used in Organic Synthesis:
Ethyl 5-benzyl-4H-1,2,4-triazole-3-carboxylate is used as a versatile intermediate in organic synthesis, enabling the production of a wide range of organic materials that can be applied across various industries.

Relevant articles and documents

Thio-seven-membered ring derivative and application thereof

The invention discloses a thio-seven-membered ring derivative or a pharmaceutical salt, a solvate, a stereoisomer and a racemate thereof. The structure of the thio-seven-membered ring derivative is shown as a general formula I, wherein the definition of e

INHIBITORS OF RECEPTOR INTERACTING PROTEIN KINASE I FOR THE TREATMENT OF DISEASE

Disclosed herein are compounds which inhibit RIPK1, pharmaceutical compositions, and methods of treatment of RIPK1 -mediated diseases, such as neurodegenerative disorders, inflammatory disorders, and cancer.

HETEROCYCLES USEFUL AS INHIBITORS OF CARBONIC ANHYDRASE

Sulfonamides and pharmaceutical compositions containing the compounds useful in controlling intraocular pressure are disclosed. Methods for controlling intraocular pressure through administration of the compositions are also disclosed.